Gerresheimer (GRRMF) Expected to Release Quarterly Earnings on Wednesday

Gerresheimer (OTCMKTS:GRRMF) is projected to issue its results before the market opens on Wednesday, November 4th. Analysts expect Gerresheimer to post earnings of $0.2854 per share and revenue of $671.16 million for the quarter.

Gerresheimer Price Performance

Gerresheimer stock opened at $37.47 on Wednesday. Gerresheimer has a 52 week low of $19.16 and a 52 week high of $37.47. The business’s 50-day moving average price is $31.38 and its 200 day moving average price is $29.60.

Analysts Set New Price Targets

Several research firms have commented on GRRMF. Deutsche Bank Aktiengesellschaft restated a “hold” rating on shares of Gerresheimer in a research report on Tuesday, August 4th. Sanford C. Bernstein raised shares of Gerresheimer from an “underperform” rating to a “market perform” rating in a report on Wednesday, July 1st. Finally, UBS Group upgraded shares of Gerresheimer from a “sell” rating to a “neutral” rating in a research note on Tuesday, August 4th. Four research analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Reduce”.

Gerresheimer Company Profile

Gerresheimer AG is a Germany-based manufacturer of packaging and drug-delivery systems for the pharmaceutical, biotechnology and cosmetics industries. The company develops and produces glass and plastic packaging, including vials, ampoules, syringes, cartridges, bottles and other containers used to store and administer medicines and other sensitive products.

Its portfolio also includes medical devices and drug-delivery solutions such as prefillable syringes, inhalers, pens and other injection-related systems.